Exports In 2020, Switzerland exported $30.2B in Blood, antisera, vaccines, toxins and cultures, making it the 3rd largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 3rd most exported product in Switzerland. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Switzerland are: Germany ($5.95B), United States ($3.54B), China ($3.08B), Belgium ($1.63B), and Japan ($1.55B).
The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Switzerland between 2019 and 2020 were Germany ($1.2B), China ($1.01B), and Belgium ($301M).
Imports In 2020, Switzerland imported $11.8B in Blood, antisera, vaccines, toxins and cultures, becoming the 4th largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 3rd most imported product in Switzerland. Switzerland imports Blood, antisera, vaccines, toxins and cultures primarily from: Germany ($3.26B), Ireland ($2.64B), United States ($2.56B), Japan ($1.12B), and Belgium ($484M).
The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Switzerland between 2019 and 2020 were Japan ($711M), Germany ($631M), and Belgium ($198M).